PALB2 Mutations and Breast-Cancer Risk

被引:27
|
作者
Evans, Michele K. [1 ]
Longo, Dan L. [1 ]
机构
[1] NIA, Hlth Dispar Res Sect, Lab Epidemiol & Populat Sci, NIH, Baltimore, MD 21224 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 371卷 / 06期
关键词
REPAIR;
D O I
10.1056/NEJMe1405784
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:566 / 568
页数:3
相关论文
共 50 条
  • [1] Breast-Cancer Risk in Families with Mutations in PALB2
    Thomas, P. S.
    Brown, P. H.
    BREAST DISEASES, 2015, 26 (03): : 206 - 208
  • [2] Breast-Cancer Risk in Families with Mutations in PALB2
    Antoniou, A. C.
    Casadei, S.
    Heikkinen, T.
    Barrowdale, D.
    Pylkaes, K.
    Roberts, J.
    Lee, A.
    Subramanian, D.
    De Leeneer, K.
    Fostira, F.
    Tomiak, E.
    Neuhausen, S. L.
    Teo, Z. L.
    Khan, S.
    Aittomaeki, K.
    Moilanen, J. S.
    Turnbull, C.
    Seal, S.
    Mannermaa, A.
    Kallioniemi, A.
    Lindeman, G. J.
    Buys, S. S.
    Andrulis, I. L.
    Radice, P.
    Tondini, C.
    Manoukian, S.
    Toland, A. E.
    Miron, P.
    Weitzel, J. N.
    Domchek, S. M.
    Poppe, B.
    Claes, K. B. M.
    Yannoukakos, D.
    Concannon, P.
    Bernstein, J. L.
    James, P. A.
    Easton, D. F.
    Goldgar, D. E.
    Hopper, J. L.
    Rahman, N.
    Peterlongo, P.
    Nevanlinna, H.
    King, M. -C.
    Couch, F. J.
    Southey, M. C.
    Winqvist, R.
    Foulkes, W. D.
    Tischkowitz, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (06): : 497 - 506
  • [3] Breast-Cancer Risk in Families with Mutations in PALB2
    Lee, Ann S. G.
    Ang, Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (17): : 1650 - 1651
  • [4] Breast-Cancer Risk in Families with Mutations in PALB2 Reply
    Antoniou, Antonis C.
    Foulkes, William D.
    Tischkowitz, Marc
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (17): : 1651 - 1652
  • [5] Breast-Cancer Risk in Families With Mutations in PALB2 EDITORIAL COMMENT
    Antoniou, Antonis C.
    Casadei, Silvia
    Heikkinen, Tuomas
    Barrowdale, Daniel
    Pylkas, Katri
    Roberts, Jonathan
    Lee, Andrew
    Subramanian, Deepak
    de Leeneer, Kim
    Fostira, Florentia
    Tomiak, Eva
    Neuhausen, Susan L.
    Teo, Zhi L.
    Khan, Sofia
    Aittomaki, Kristiina
    Moilanen, Jukka S.
    Turnbull, Clare
    Seal, Sheila
    Mannermaa, Arto
    Kallioniemi, Anne
    Lindeman, Geoffrey J.
    Buys, Saundra S.
    Andrulis, Irene L.
    Radice, Paolo
    Tondini, Carlo
    Manoukian, Siranoush
    Toland, Amanda E.
    Miron, Penelope
    Weitzel, Jeffrey N.
    Domchek, Susan M.
    Poppe, Bruce
    Claes, Kathleen B. M.
    Yannoukakos, Drakoulis
    Concannon, Patrick
    Bernstein, Jonine L.
    James, Paul A.
    Easton, Douglas F.
    Goldgar, David E.
    Hopper, John L.
    Rahman, Nazneen
    Peterlongo, Paolo
    Nevanlinna, Heli
    King, Mary-Claire
    Couch, Fergus J.
    Southey, Melissa C.
    Winqvist, Robert
    Foulkes, William D.
    Tischkowitz, Marc
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2014, 69 (11) : 659 - 660
  • [6] The risk of breast cancer due to PALB2 gene mutations
    Wesola, Marta
    Jelen, Michal
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (02): : 339 - 342
  • [7] Are PALB2 mutations associated with increased risk of male breast cancer?
    de Chalon, A. Sauty
    Teo, Z.
    Park, D. J.
    Odefrey, F. A.
    Hopper, J. L.
    Southey, M. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (01) : 253 - 255
  • [8] Are PALB2 mutations associated with increased risk of male breast cancer?
    A. Sauty de Chalon
    Z. Teo
    D. J. Park
    F. A. Odefrey
    J. L. Hopper
    M. C. Southey
    Breast Cancer Research and Treatment, 2010, 121 : 253 - 255
  • [9] PALB2 mutations in familial breast and pancreatic cancer
    Erin W. Hofstatter
    Susan M. Domchek
    Alexander Miron
    Judy Garber
    Molin Wang
    Kathryn Componeschi
    Leigh Boghossian
    Penelope L. Miron
    Katherine L. Nathanson
    Nadine Tung
    Familial Cancer, 2011, 10 : 225 - 231
  • [10] PALB2 -: new breast-cancer susceptibility gene
    Simpson, Sally
    LANCET ONCOLOGY, 2007, 8 (02): : 105 - 105